ARTICLE | Clinical News
Composite Cultured Skin regulatory update
February 26, 2001 8:00 AM UTC
ORTC received a humanitarian device exemption from the FDA to use its CCS in patients with Recessive Dystrophic Epidermolysis Bullosa (ulcerations of the hands and feet) undergoing hand reconstruction...